Difficult management of abnormal uterine bleeding in Glanzmann thrombasthenia

case-report OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-11

This paper describes the challenging medical and surgical management of abnormal uterine bleeding in two patients with the rare hematological disorder Glanzmann thrombasthenia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text

This paper reports two case histories of patients with Glanzmann thrombasthenia presenting with abnormal uterine bleeding, a condition caused by impaired platelet aggregation due to defects in glycoprotein IIb/IIIa. Across the cases, clinicians used different approaches to control heavy menstrual bleeding, including medical management with tranexamic acid and hormonal therapy in one patient and surgical treatment for a tubo-ovarian endometrioma with laparoscopic adhesiolysis and cyst aspiration in the other, addressing heavy bleeding and dysmenorrhoea. The authors note that the rarity of Glanzmann thrombasthenia makes prevention and control of bleeding challenging and that these are case reports, which should not be used in isolation to guide treatment choices. Relevance to endometriosis: the paper’s second case involves a tubo-ovarian endometrioma presenting with heavy menstrual bleeding and dysmenorrhoea, though the paper’s main focus is difficult abnormal uterine bleeding management in Glanzmann thrombasthenia rather than endometriosis or adenomyosis broadly.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Glanzmann thrombasthenia (GT) is a rare haematological disorder with abnormal platelet surface receptor glycoprotein IIb/IIIa, resulting in faulty platelet aggregation. Patients with GT may present with spontaneous bleeding after trauma or surgery. As the disease is rare, controlling and preventing bleeding in such patients is challenging. We report two cases of previously diagnosed GT presented with abnormal uterine bleeding. The first case was managed medically with tranexamic acid and hormonal therapy to control menstrual bleeding. In contrast, the second case involved a tubo-ovarian endometrioma presenting with heavy menstrual bleeding (HMB) and dysmenorrhoea, which was treated with laparoscopic adhesiolysis and cyst aspiration. Management of HMB and endometriosis is challenging, especially when using invasive procedures such as laparoscopy. Physicians should be familiar with the characteristics of the disease and all possible treatment options to halt the bleeding to avoid morbidity in patients.
Full text 1,987 characters · extracted from oa-doi-fallback · click to expand
Article Text Abstract Glanzmann thrombasthenia (GT) is a rare haematological disorder with abnormal platelet surface receptor glycoprotein IIb/IIIa, resulting in faulty platelet aggregation. Patients with GT may present with spontaneous bleeding after trauma or surgery. As the disease is rare, controlling and preventing bleeding in such patients is challenging. We report two cases of previously diagnosed GT presented with abnormal uterine bleeding. The first case was managed medically with tranexamic acid and hormonal therapy to control menstrual bleeding. In contrast, the second case involved a tubo-ovarian endometrioma presenting with heavy menstrual bleeding (HMB) and dysmenorrhoea, which was treated with laparoscopic adhesiolysis and cyst aspiration. Management of HMB and endometriosis is challenging, especially when using invasive procedures such as laparoscopy. Physicians should be familiar with the characteristics of the disease and all possible treatment options to halt the bleeding to avoid morbidity in patients. - Uterus - Obstetrics and gynaecology - Haematology (incl blood transfusion) Statistics from Altmetric.com Footnotes Contributors The following authors were directly involved in the patient’s care: MM, SS, SP and SRS. The following author is the clinician in charge of the clinical care of the patient, who supervised the preparation of the manuscript, was responsible for obtaining informed consent from the patient/guardian/family members and is responsible for the overall integrity of the content of the manuscript: SS. SS will act as the guarantor for the paper. Funding No funds have been utilized for this study. Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometriomadysmenorrhea

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 1
tranexamic acid

Source provenance

europepmc
last seen: 2026-06-17T06:13:18.893374+00:00
pubmed
last seen: 2026-06-17T06:10:25.567277+00:00
scilite
last seen: 2026-05-18T04:26:01.642840+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine